One of the remarkable aspects of DNA methylation is its potential reversibility. Unlike genetic mutations, epigenetic modifications like methylation can sometimes be reversed, which offers potential therapeutic avenues. Certain drugs, known as epigenetic drugs, aim to modify methylation patterns to restore normal gene function. However, the complexity of the epigenome and the potential for off-target effects make this a challenging area of research.
